Thu. 9 May 2024, 5:02pm ET
Benzinga
Earnings, Earnings Misses, News
Lantern Pharma (NASDAQ:LTRN) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.43) by 18.6 percent. This is a 41.67 percent decrease over losses of $(0.36) per share from the same period last year.